-
1
-
-
0242290408
-
Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity
-
Valko, K.; Nunhuck, S.; Bevan, C.; Abraham, M. H.; Reynolds, D. P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity J. Pharm. Sci. 2003, 92, 2236-2248
-
(2003)
J. Pharm. Sci.
, vol.92
, pp. 2236-2248
-
-
Valko, K.1
Nunhuck, S.2
Bevan, C.3
Abraham, M.H.4
Reynolds, D.P.5
-
2
-
-
33846230530
-
Plasma protein binding affinity and its relationship to molecular structure: An in-silico analysis
-
Gleeson, M. P. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis J. Med. Chem. 2007, 50, 101-112
-
(2007)
J. Med. Chem.
, vol.50
, pp. 101-112
-
-
Gleeson, M.P.1
-
4
-
-
21444433359
-
Strategies to optimize brain penetration in drug discovery
-
Liu, X.; Chen, C. Strategies to optimize brain penetration in drug discovery Curr. Opin. Drug Discovery Dev. 2005, 8, 505-512
-
(2005)
Curr. Opin. Drug Discovery Dev.
, vol.8
, pp. 505-512
-
-
Liu, X.1
Chen, C.2
-
5
-
-
34447503927
-
The importance of plasma protein binding in drug discovery
-
Trainor, G. The importance of plasma protein binding in drug discovery Expert Opin. Drug Discovery 2007, 2, 51-64
-
(2007)
Expert Opin. Drug Discovery
, vol.2
, pp. 51-64
-
-
Trainor, G.1
-
6
-
-
45949107902
-
On the rate and extent of drug delivery to the brain
-
Hammarlund-Udenaes, M.; Friden, M.; Syvanen, S.; Gupta, A. On the rate and extent of drug delivery to the brain Pharm. Res. 2008, 25, 1737-1750
-
(2008)
Pharm. Res.
, vol.25
, pp. 1737-1750
-
-
Hammarlund-Udenaes, M.1
Friden, M.2
Syvanen, S.3
Gupta, A.4
-
7
-
-
38849136513
-
CSF as a surrogate for assessing CNS exposure: An industrial perspective
-
Lin, J. H. CSF as a surrogate for assessing CNS exposure: an industrial perspective Curr. Drug Metab. 2008, 9, 46-59
-
(2008)
Curr. Drug Metab.
, vol.9
, pp. 46-59
-
-
Lin, J.H.1
-
8
-
-
76649085489
-
Significance of protein binding in pharmacokinetics and pharmacodynamics
-
Schmidt, S.; Gonzalez, D.; Derendorf, H. Significance of protein binding in pharmacokinetics and pharmacodynamics J. Pharm. Sci. 2010, 99, 1107-1122
-
(2010)
J. Pharm. Sci.
, vol.99
, pp. 1107-1122
-
-
Schmidt, S.1
Gonzalez, D.2
Derendorf, H.3
-
9
-
-
78649706279
-
The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery
-
Smith, D. A.; Di, L.; Kerns, E. H. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery Nat. Rev. Drug Discovery 2010, 9, 929-939
-
(2010)
Nat. Rev. Drug Discovery
, vol.9
, pp. 929-939
-
-
Smith, D.A.1
Di, L.2
Kerns, E.H.3
-
10
-
-
33847411025
-
Misuse of the well-stirred model of hepatic drug clearance
-
Yang, J.; Jamei, M.; Yeo, K. R.; Rostami-Hodjegan, A.; Tucker, G. T. Misuse of the well-stirred model of hepatic drug clearance Drug Metab. Dispos. 2007, 35, 501-502
-
(2007)
Drug Metab. Dispos.
, vol.35
, pp. 501-502
-
-
Yang, J.1
Jamei, M.2
Yeo, K.R.3
Rostami-Hodjegan, A.4
Tucker, G.T.5
-
11
-
-
0037407697
-
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
-
Banker, M. J.; Clark, T. H.; Williams, J. A. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding J. Pharm. Sci. 2003, 92, 967-974
-
(2003)
J. Pharm. Sci.
, vol.92
, pp. 967-974
-
-
Banker, M.J.1
Clark, T.H.2
Williams, J.A.3
-
12
-
-
0035038596
-
Development of a high throughput equilibrium dialysis method
-
Kariv, I.; Cao, H.; Oldenburg, K. R. Development of a high throughput equilibrium dialysis method J. Pharm. Sci. 2001, 90, 580-587
-
(2001)
J. Pharm. Sci.
, vol.90
, pp. 580-587
-
-
Kariv, I.1
Cao, H.2
Oldenburg, K.R.3
-
13
-
-
0141537961
-
Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography-tandem mass spectrometry
-
Fung, E. N.; Chen, Y. H.; Lau, Y. Y. Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography-tandem mass spectrometry J. Chromatogr., B: Anal. Technol. Biomed Life Sci. 2003, 795, 187-194
-
(2003)
J. Chromatogr., B: Anal. Technol. Biomed Life Sci.
, vol.795
, pp. 187-194
-
-
Fung, E.N.1
Chen, Y.H.2
Lau, Y.Y.3
-
14
-
-
29044432751
-
High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry
-
Wan, H.; Rehngren, M. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry J. Chromatogr., A 2006, 1102, 125-134
-
(2006)
J. Chromatogr., A
, vol.1102
, pp. 125-134
-
-
Wan, H.1
Rehngren, M.2
-
15
-
-
17144395222
-
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach
-
Aureli, L.; Cruciani, G.; Cesta, M. C.; Anacardio, R.; De Simone, L.; Moriconi, A. Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach J. Med. Chem. 2005, 48, 2469-2479
-
(2005)
J. Med. Chem.
, vol.48
, pp. 2469-2479
-
-
Aureli, L.1
Cruciani, G.2
Cesta, M.C.3
Anacardio, R.4
De Simone, L.5
Moriconi, A.6
-
16
-
-
33845748281
-
Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion
-
Wang, J.; Krudy, G.; Xie, X. Q.; Wu, C.; Holland, G. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion J. Chem. Inf. Model. 2006, 46, 2674-2683
-
(2006)
J. Chem. Inf. Model.
, vol.46
, pp. 2674-2683
-
-
Wang, J.1
Krudy, G.2
Xie, X.Q.3
Wu, C.4
Holland, G.5
-
17
-
-
2642548329
-
Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds
-
Yamazaki, K.; Kanaoka, M. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds J. Pharm. Sci. 2004, 93, 1480-1494
-
(2004)
J. Pharm. Sci.
, vol.93
, pp. 1480-1494
-
-
Yamazaki, K.1
Kanaoka, M.2
-
18
-
-
0036828938
-
Predicting plasma protein binding of drugs: A new approach
-
Kratochwil, N. A.; Huber, W.; Muller, F.; Kansy, M.; Gerber, P. R. Predicting plasma protein binding of drugs: a new approach Biochem. Pharmacol. 2002, 64, 1355-1374
-
(2002)
Biochem. Pharmacol.
, vol.64
, pp. 1355-1374
-
-
Kratochwil, N.A.1
Huber, W.2
Muller, F.3
Kansy, M.4
Gerber, P.R.5
-
19
-
-
0036874825
-
Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery
-
Kalvass, J. C.; Maurer, T. S. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery Biopharm. Drug Dispos. 2002, 23, 327-338
-
(2002)
Biopharm. Drug Dispos.
, vol.23
, pp. 327-338
-
-
Kalvass, J.C.1
Maurer, T.S.2
-
20
-
-
56749183619
-
Toward an improved prediction of human in vivo brain penetration
-
Summerfield, S. G.; Lucas, A. J.; Porter, R. A.; Jeffrey, P.; Gunn, R. N.; Read, K. R.; Stevens, A. J.; Metcalf, A. C.; Osuna, M. C.; Kilford, P. J.; Passchier, J.; Ruffo, A. D. Toward an improved prediction of human in vivo brain penetration Xenobiotica 2008, 38, 1518-1535
-
(2008)
Xenobiotica
, vol.38
, pp. 1518-1535
-
-
Summerfield, S.G.1
Lucas, A.J.2
Porter, R.A.3
Jeffrey, P.4
Gunn, R.N.5
Read, K.R.6
Stevens, A.J.7
Metcalf, A.C.8
Osuna, M.C.9
Kilford, P.J.10
Passchier, J.11
Ruffo, A.D.12
-
21
-
-
0031893997
-
Contribution of alpha 1-acid glycoprotein to species difference in lincosamides-plasma protein binding kinetics
-
Son, D. S.; Osabe, M.; Shimoda, M.; Kokue, E. Contribution of alpha 1-acid glycoprotein to species difference in lincosamides-plasma protein binding kinetics J. Vet. Pharmacol. Ther. 1998, 21, 34-40
-
(1998)
J. Vet. Pharmacol. Ther.
, vol.21
, pp. 34-40
-
-
Son, D.S.1
Osabe, M.2
Shimoda, M.3
Kokue, E.4
-
22
-
-
0034935629
-
Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolites
-
Endo, H.; Yoshida, H.; Hasegawa, M.; Ohmi, N.; Horiuchi, N.; Hamada, Y.; Higuchi, S. Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolites Biol. Pharm. Bull. 2001, 24, 800-805
-
(2001)
Biol. Pharm. Bull.
, vol.24
, pp. 800-805
-
-
Endo, H.1
Yoshida, H.2
Hasegawa, M.3
Ohmi, N.4
Horiuchi, N.5
Hamada, Y.6
Higuchi, S.7
-
23
-
-
70349557614
-
Enantioselective plasma protein binding of propafenone: Mechanism, drug interaction, and species difference
-
Hong, Y.; Tang, Y.; Zeng, S. Enantioselective plasma protein binding of propafenone: mechanism, drug interaction, and species difference Chirality 2009, 21, 692-698
-
(2009)
Chirality
, vol.21
, pp. 692-698
-
-
Hong, Y.1
Tang, Y.2
Zeng, S.3
-
24
-
-
53149121998
-
Cross-species differential plasma protein binding of MBX-102/JNJ39659100: A novel PPAR-gamma agonist
-
Clarke, H. J.; Gregoire, F.; Ma, F.; Martin, R.; Zhao, S.; Lavan, B. E. Cross-species differential plasma protein binding of MBX-102/JNJ39659100: a novel PPAR-gamma agonist PPAR Res. 2008, 2008, 1-10
-
(2008)
PPAR Res.
, vol.2008
, pp. 1-10
-
-
Clarke, H.J.1
Gregoire, F.2
Ma, F.3
Martin, R.4
Zhao, S.5
Lavan, B.E.6
-
25
-
-
84876854153
-
Spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid beta in a higher species
-
Hunt, K. W.; Cook, A. W.; Watts, R. J.; Clark, C. T.; Vigers, G.; Smith, D.; Metcalf, A. T.; Gunawardana, I. W.; Burkard, M.; Cox, A. A.; Geck Do, M. K.; Dutcher, D.; Thomas, A. A.; Rana, S.; Kallan, N. C.; DeLisle, R. K.; Rizzi, J. P.; Regal, K.; Sammond, D.; Groneberg, R.; Siu, M.; Purkey, H.; Lyssikatos, J. P.; Marlow, A.; Liu, X.; Tang, T. P. Spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid beta in a higher species J. Med. Chem. 2013, 56, 3379-3403
-
(2013)
J. Med. Chem.
, vol.56
, pp. 3379-3403
-
-
Hunt, K.W.1
Cook, A.W.2
Watts, R.J.3
Clark, C.T.4
Vigers, G.5
Smith, D.6
Metcalf, A.T.7
Gunawardana, I.W.8
Burkard, M.9
Cox, A.A.10
Geck Do, M.K.11
Dutcher, D.12
Thomas, A.A.13
Rana, S.14
Kallan, N.C.15
Delisle, R.K.16
Rizzi, J.P.17
Regal, K.18
Sammond, D.19
Groneberg, R.20
Siu, M.21
Purkey, H.22
Lyssikatos, J.P.23
Marlow, A.24
Liu, X.25
Tang, T.P.26
more..
-
26
-
-
0141481966
-
Protein binding in antiretroviral therapies
-
Boffito, M.; Back, D. J.; Blaschke, T. F.; Rowland, M.; Bertz, R. J.; Gerber, J. G.; Miller, V. Protein binding in antiretroviral therapies AIDS Res. Hum. Retroviruses 2003, 19, 825-835
-
(2003)
AIDS Res. Hum. Retroviruses
, vol.19
, pp. 825-835
-
-
Boffito, M.1
Back, D.J.2
Blaschke, T.F.3
Rowland, M.4
Bertz, R.J.5
Gerber, J.G.6
Miller, V.7
-
27
-
-
0032566902
-
Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus
-
Molla, A.; Vasavanonda, S.; Kumar, G.; Sham, H. L.; Johnson, M.; Grabowski, B.; Denissen, J. F.; Kohlbrenner, W.; Plattner, J. J.; Leonard, J. M.; Norbeck, D. W.; Kempf, D. J. Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus Virology 1998, 250, 255-262
-
(1998)
Virology
, vol.250
, pp. 255-262
-
-
Molla, A.1
Vasavanonda, S.2
Kumar, G.3
Sham, H.L.4
Johnson, M.5
Grabowski, B.6
Denissen, J.F.7
Kohlbrenner, W.8
Plattner, J.J.9
Leonard, J.M.10
Norbeck, D.W.11
Kempf, D.J.12
-
28
-
-
34548071206
-
In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids
-
Friden, M.; Gupta, A.; Antonsson, M.; Bredberg, U.; Hammarlund-Udenaes, M. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids Drug Metab. Dispos. 2007, 35, 1711-1719
-
(2007)
Drug Metab. Dispos.
, vol.35
, pp. 1711-1719
-
-
Friden, M.1
Gupta, A.2
Antonsson, M.3
Bredberg, U.4
Hammarlund-Udenaes, M.5
-
29
-
-
84879343782
-
Intracellular drug concentrations and transporters: Measurement, modeling, and implications for the liver
-
Chu, X.; Korzekwa, K.; Elsby, R.; Fenner, K.; Galetin, A.; Lai, Y.; Matsson, P.; Moss, A.; Nagar, S.; Rosania, G. R.; Bai, J. P.; Polli, J. W.; Sugiyama, Y.; Brouwer, K. L. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver Clin. Pharmacol. Ther. 2013, 94, 126-141
-
(2013)
Clin. Pharmacol. Ther.
, vol.94
, pp. 126-141
-
-
Chu, X.1
Korzekwa, K.2
Elsby, R.3
Fenner, K.4
Galetin, A.5
Lai, Y.6
Matsson, P.7
Moss, A.8
Nagar, S.9
Rosania, G.R.10
Bai, J.P.11
Polli, J.W.12
Sugiyama, Y.13
Brouwer, K.L.14
-
30
-
-
84878631164
-
Rapid measurement of intracellular unbound drug concentrations
-
Mateus, A.; Matsson, P.; Artursson, P. Rapid measurement of intracellular unbound drug concentrations Mol. Pharmaceutics 2013, 10, 2467-2478
-
(2013)
Mol. Pharmaceutics
, vol.10
, pp. 2467-2478
-
-
Mateus, A.1
Matsson, P.2
Artursson, P.3
-
31
-
-
84886533717
-
Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue
-
Pfeifer, N. D.; Harris, K. B.; Yan, G. Z.; Brouwer, K. L. Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue Drug Metab. Dispos. 2013, 41, 1949-1956
-
(2013)
Drug Metab. Dispos.
, vol.41
, pp. 1949-1956
-
-
Pfeifer, N.D.1
Harris, K.B.2
Yan, G.Z.3
Brouwer, K.L.4
-
32
-
-
0018190444
-
Hepatic elimination of flowing substrates: The distributed model
-
Bass, L.; Robinson, P.; Bracken, A. J. Hepatic elimination of flowing substrates: the distributed model J. Theor. Biol. 1978, 72, 161-184
-
(1978)
J. Theor. Biol.
, vol.72
, pp. 161-184
-
-
Bass, L.1
Robinson, P.2
Bracken, A.J.3
-
33
-
-
0017603437
-
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
-
Pang, K. S.; Rowland, M. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance J. Pharmacokinet. Biopharm. 1977, 5, 625-653
-
(1977)
J. Pharmacokinet. Biopharm.
, vol.5
, pp. 625-653
-
-
Pang, K.S.1
Rowland, M.2
-
34
-
-
0017603438
-
Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation
-
Pang, K. S.; Rowland, M. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation J. Pharmacokinet. Biopharm. 1977, 5, 655-680
-
(1977)
J. Pharmacokinet. Biopharm.
, vol.5
, pp. 655-680
-
-
Pang, K.S.1
Rowland, M.2
-
35
-
-
0017565370
-
Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation
-
Pang, K. S.; Rowland, M. Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation J. Pharmacokinet. Biopharm. 1977, 5, 681-699
-
(1977)
J. Pharmacokinet. Biopharm.
, vol.5
, pp. 681-699
-
-
Pang, K.S.1
Rowland, M.2
-
36
-
-
0022549973
-
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations
-
Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations J. Pharmacokinet. Biopharm. 1986, 14, 227-260
-
(1986)
J. Pharmacokinet. Biopharm.
, vol.14
, pp. 227-260
-
-
Roberts, M.S.1
Rowland, M.2
-
37
-
-
0022552317
-
A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity
-
Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity J. Pharmacokinet. Biopharm. 1986, 14, 261-288
-
(1986)
J. Pharmacokinet. Biopharm.
, vol.14
, pp. 261-288
-
-
Roberts, M.S.1
Rowland, M.2
-
38
-
-
0022922022
-
A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics
-
Roberts, M. S.; Rowland, M. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics J. Pharmacokinet. Biopharm. 1986, 14, 289-308
-
(1986)
J. Pharmacokinet. Biopharm.
, vol.14
, pp. 289-308
-
-
Roberts, M.S.1
Rowland, M.2
-
39
-
-
0018163388
-
Hepatic transport kinetics and plasma disappearance curves: Distributed modeling versus conventional approach
-
Forker, E. L.; Luxon, B. Hepatic transport kinetics and plasma disappearance curves: distributed modeling versus conventional approach Am. J. Physiol. 1978, 235, E648-E660
-
(1978)
Am. J. Physiol.
, vol.235
, pp. 648-E660
-
-
Forker, E.L.1
Luxon, B.2
-
40
-
-
77949821065
-
On the influence of protein binding on pharmacological activity of drugs
-
Berezhkovskiy, L. M. On the influence of protein binding on pharmacological activity of drugs J. Pharm. Sci. 2010, 99, 2153-2165
-
(2010)
J. Pharm. Sci.
, vol.99
, pp. 2153-2165
-
-
Berezhkovskiy, L.M.1
-
42
-
-
79551662332
-
Do we need to optimize plasma protein and tissue binding in drug discovery?
-
Liu, X.; Chen, C.; Hop, C. E. Do we need to optimize plasma protein and tissue binding in drug discovery? Curr. Top Med. Chem. 2011, 11, 450-466
-
(2011)
Curr. Top Med. Chem.
, vol.11
, pp. 450-466
-
-
Liu, X.1
Chen, C.2
Hop, C.E.3
-
43
-
-
0021361240
-
Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding
-
Jones, D. B.; Morgan, D. J.; Mihaly, G. W.; Webster, L. K.; Smallwood, R. A. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding J. Pharmacol. Exp. Ther. 1984, 229, 522-526
-
(1984)
J. Pharmacol. Exp. Ther.
, vol.229
, pp. 522-526
-
-
Jones, D.B.1
Morgan, D.J.2
Mihaly, G.W.3
Webster, L.K.4
Smallwood, R.A.5
-
44
-
-
0023682627
-
Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: Comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models
-
Smallwood, R. H.; Morgan, D. J.; Mihaly, G. W.; Jones, D. B.; Smallwood, R. A. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models J. Pharmacokinet. Biopharm. 1988, 16, 377-396
-
(1988)
J. Pharmacokinet. Biopharm.
, vol.16
, pp. 377-396
-
-
Smallwood, R.H.1
Morgan, D.J.2
Mihaly, G.W.3
Jones, D.B.4
Smallwood, R.A.5
-
45
-
-
0018750411
-
Albumin-deficient rat mutant
-
Nagase, S.; Shimamune, K.; Shumiya, S. Albumin-deficient rat mutant Science 1979, 205, 590-591
-
(1979)
Science
, vol.205
, pp. 590-591
-
-
Nagase, S.1
Shimamune, K.2
Shumiya, S.3
-
46
-
-
48849115495
-
Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR)
-
Miida, H.; Arakawa, S.; Shibaya, Y.; Honda, K.; Kiyosawa, N.; Watanabe, K.; Manabe, S.; Takasaki, W.; Ueno, K. Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR) J. Toxicol. Sci. 2008, 33, 349-361
-
(2008)
J. Toxicol. Sci.
, vol.33
, pp. 349-361
-
-
Miida, H.1
Arakawa, S.2
Shibaya, Y.3
Honda, K.4
Kiyosawa, N.5
Watanabe, K.6
Manabe, S.7
Takasaki, W.8
Ueno, K.9
-
47
-
-
33845899457
-
Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-chloro-4-[ N -(2-methylphenyl)-ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidine-2-yl]-methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism
-
Ito, T.; Takahashi, M.; Sudo, K.; Sugiyama, Y. Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-chloro-4-[ N -(2-methylphenyl)-ureido]phenylacetyl]-(4 S)-fluoro-(2 S)-pyrrolidine-2-yl]-methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism J. Pharmacol. Exp. Ther. 2007, 320, 124-132
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.320
, pp. 124-132
-
-
Ito, T.1
Takahashi, M.2
Sudo, K.3
Sugiyama, Y.4
-
48
-
-
0036218554
-
Changes in plasma protein binding have little clinical relevance
-
Benet, L. Z.; Hoener, B. A. Changes in plasma protein binding have little clinical relevance Clin. Pharmacol. Ther. 2002, 71, 115-121
-
(2002)
Clin. Pharmacol. Ther.
, vol.71
, pp. 115-121
-
-
Benet, L.Z.1
Hoener, B.A.2
-
49
-
-
0036799286
-
The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics
-
Toutain, P. L.; del Castillo, J. R.; Bousquet-Melou, A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics Res. Vet. Sci. 2002, 73, 105-114
-
(2002)
Res. Vet. Sci.
, vol.73
, pp. 105-114
-
-
Toutain, P.L.1
Del Castillo, J.R.2
Bousquet-Melou, A.3
-
50
-
-
0031442434
-
Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat
-
Blakey, G. E.; Nestorov, I. A.; Arundel, P. A.; Aarons, L. J.; Rowland, M. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat J. Pharmacokinet. Biopharm. 1997, 25, 277-312
-
(1997)
J. Pharmacokinet. Biopharm.
, vol.25
, pp. 277-312
-
-
Blakey, G.E.1
Nestorov, I.A.2
Arundel, P.A.3
Aarons, L.J.4
Rowland, M.5
-
51
-
-
46449114275
-
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
-
Obach, R. S.; Lombardo, F.; Waters, N. J. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds Drug Metab. Dispos. 2008, 36, 1385-1405
-
(2008)
Drug Metab. Dispos.
, vol.36
, pp. 1385-1405
-
-
Obach, R.S.1
Lombardo, F.2
Waters, N.J.3
-
52
-
-
0001394264
-
Apparent volume of distribution
-
In, 2 nd ed. Marcel Dekker: New York, Vol.
-
Gibaldi, M.; Perrier, D. Apparent volume of distribution. In Pharmacokinetics, 2 nd ed.; Marcel Dekker: New York, 1982; Vol. 15, pp 199-219.
-
(1982)
Pharmacokinetics
, vol.15
, pp. 199-219
-
-
Gibaldi, M.1
Perrier, D.2
-
53
-
-
1242273811
-
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics
-
Lombardo, F.; Obach, R. S.; Shalaeva, M. Y.; Gao, F. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics J. Med. Chem. 2004, 47, 1242-1250
-
(2004)
J. Med. Chem.
, vol.47
, pp. 1242-1250
-
-
Lombardo, F.1
Obach, R.S.2
Shalaeva, M.Y.3
Gao, F.4
-
54
-
-
0037142338
-
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data
-
Lombardo, F.; Obach, R. S.; Shalaeva, M. Y.; Gao, F. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data J. Med. Chem. 2002, 45, 2867-2876
-
(2002)
J. Med. Chem.
, vol.45
, pp. 2867-2876
-
-
Lombardo, F.1
Obach, R.S.2
Shalaeva, M.Y.3
Gao, F.4
-
55
-
-
0029160004
-
Effective half-life in clinical pharmacology
-
Boxenbaum, H.; Battle, M. Effective half-life in clinical pharmacology J. Clin. Pharmacol. 1995, 35, 763-766
-
(1995)
J. Clin. Pharmacol.
, vol.35
, pp. 763-766
-
-
Boxenbaum, H.1
Battle, M.2
-
56
-
-
72449185642
-
Addressing central nervous system (CNS) penetration in drug discovery: Basics and implications of the evolving new concept
-
Reichel, A. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept Chem. Biodiversity 2009, 6, 2030-2049
-
(2009)
Chem. Biodiversity
, vol.6
, pp. 2030-2049
-
-
Reichel, A.1
-
57
-
-
42449100856
-
Progress in brain penetration evaluation in drug discovery and development
-
Liu, X.; Chen, C.; Smith, B. J. Progress in brain penetration evaluation in drug discovery and development J. Pharmacol. Exp. Ther. 2008, 325, 349-356
-
(2008)
J. Pharmacol. Exp. Ther.
, vol.325
, pp. 349-356
-
-
Liu, X.1
Chen, C.2
Smith, B.J.3
-
58
-
-
84872319925
-
Demystifying brain penetration in central nervous system drug discovery
-
Di, L.; Rong, H.; Feng, B. Demystifying brain penetration in central nervous system drug discovery J. Med. Chem. 2013, 56, 2-12
-
(2013)
J. Med. Chem.
, vol.56
, pp. 2-12
-
-
Di, L.1
Rong, H.2
Feng, B.3
-
59
-
-
63349088174
-
Methodologies to assess brain drug delivery in lead optimization
-
Hammarlund-Udenaes, M.; Bredberg, U.; Friden, M. Methodologies to assess brain drug delivery in lead optimization Curr. Top Med. Chem. 2009, 9, 148-162
-
(2009)
Curr. Top Med. Chem.
, vol.9
, pp. 148-162
-
-
Hammarlund-Udenaes, M.1
Bredberg, U.2
Friden, M.3
-
60
-
-
0030898087
-
Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method
-
Hammarlund-Udenaes, M.; Paalzow, L. K.; de Lange, E. C. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method Pharm. Res. 1997, 14, 128-134
-
(1997)
Pharm. Res.
, vol.14
, pp. 128-134
-
-
Hammarlund-Udenaes, M.1
Paalzow, L.K.2
De Lange, E.C.3
-
61
-
-
11144290156
-
Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice
-
Maurer, T. S.; Debartolo, D. B.; Tess, D. A.; Scott, D. O. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice Drug Metab. Dispos. 2005, 33, 175-181
-
(2005)
Drug Metab. Dispos.
, vol.33
, pp. 175-181
-
-
Maurer, T.S.1
Debartolo, D.B.2
Tess, D.A.3
Scott, D.O.4
-
62
-
-
19944425121
-
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model
-
Doran, A.; Obach, R. S.; Smith, B. J.; Hosea, N. A.; Becker, S.; Callegari, E.; Chen, C.; Chen, X.; Choo, E.; Cianfrogna, J.; Cox, L. M.; Gibbs, J. P.; Gibbs, M. A.; Hatch, H.; Hop, C. E.; Kasman, I. N.; Laperle, J.; Liu, J.; Liu, X.; Logman, M.; Maclin, D.; Nedza, F. M.; Nelson, F.; Olson, E.; Rahematpura, S.; Raunig, D.; Rogers, S.; Schmidt, K.; Spracklin, D. K.; Szewc, M.; Troutman, M.; Tseng, E.; Tu, M.; Van Deusen, J. W.; Venkatakrishnan, K.; Walens, G.; Wang, E. Q.; Wong, D.; Yasgar, A. S.; Zhang, C. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model Drug Metab. Dispos. 2005, 33, 165-174
-
(2005)
Drug Metab. Dispos.
, vol.33
, pp. 165-174
-
-
Doran, A.1
Obach, R.S.2
Smith, B.J.3
Hosea, N.A.4
Becker, S.5
Callegari, E.6
Chen, C.7
Chen, X.8
Choo, E.9
Cianfrogna, J.10
Cox, L.M.11
Gibbs, J.P.12
Gibbs, M.A.13
Hatch, H.14
Hop, C.E.15
Kasman, I.N.16
Laperle, J.17
Liu, J.18
Liu, X.19
Logman, M.20
Maclin, D.21
Nedza, F.M.22
Nelson, F.23
Olson, E.24
Rahematpura, S.25
Raunig, D.26
Rogers, S.27
Schmidt, K.28
Spracklin, D.K.29
Szewc, M.30
Troutman, M.31
Tseng, E.32
Tu, M.33
Van Deusen, J.W.34
Venkatakrishnan, K.35
Walens, G.36
Wang, E.Q.37
Wong, D.38
Yasgar, A.S.39
Zhang, C.40
more..
-
63
-
-
33644756715
-
Improving the in vitro prediction of in vivo central nervous system penetration: Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
-
Summerfield, S. G.; Stevens, A. J.; Cutler, L.; del Carmen Osuna, M.; Hammond, B.; Tang, S. P.; Hersey, A.; Spalding, D. J.; Jeffrey, P. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain J. Pharmacol. Exp. Ther. 2006, 316, 1282-1290
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.316
, pp. 1282-1290
-
-
Summerfield, S.G.1
Stevens, A.J.2
Cutler, L.3
Del Carmen Osuna, M.4
Hammond, B.5
Tang, S.P.6
Hersey, A.7
Spalding, D.J.8
Jeffrey, P.9
-
64
-
-
67649408864
-
Unbound brain concentration determines receptor occupancy: A correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats
-
Liu, X.; Vilenski, O.; Kwan, J.; Apparsundaram, S.; Weikert, R. Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats Drug Metab. Dispos. 2009, 37, 1548-1556
-
(2009)
Drug Metab. Dispos.
, vol.37
, pp. 1548-1556
-
-
Liu, X.1
Vilenski, O.2
Kwan, J.3
Apparsundaram, S.4
Weikert, R.5
|